OmniAb, Inc.

NasdaqGM:OABI Stock Report

Market Cap: US$266.3m

OmniAb Management

Management criteria checks 2/4

OmniAb's CEO is Matt Foehr, appointed in Nov 2022, has a tenure of 3.17 years. total yearly compensation is $3.65M, comprised of 16.3% salary and 83.7% bonuses, including company stock and options. directly owns 3.03% of the company’s shares, worth $8.07M. The average tenure of the management team and the board of directors is 3.2 years and 3.2 years respectively.

Key information

Matt Foehr

Chief executive officer

US$3.6m

Total compensation

CEO salary percentage16.29%
CEO tenure3.2yrs
CEO ownership3.0%
Management average tenure3.2yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

OmniAb, Inc. (NASDAQ:OABI) Not Lagging Industry On Growth Or Pricing

Oct 10
OmniAb, Inc. (NASDAQ:OABI) Not Lagging Industry On Growth Or Pricing

Analyst Estimates: Here's What Brokers Think Of OmniAb, Inc. (NASDAQ:OABI) After Its Second-Quarter Report

Aug 09
Analyst Estimates: Here's What Brokers Think Of OmniAb, Inc. (NASDAQ:OABI) After Its Second-Quarter Report

Market Participants Recognise OmniAb, Inc.'s (NASDAQ:OABI) Revenues Pushing Shares 38% Higher

Jul 09
Market Participants Recognise OmniAb, Inc.'s (NASDAQ:OABI) Revenues Pushing Shares 38% Higher

OmniAb: Too Much Risk, Not Enough Reward

May 12

Earnings Release: Here's Why Analysts Cut Their OmniAb, Inc. (NASDAQ:OABI) Price Target To US$7.88

May 11
Earnings Release: Here's Why Analysts Cut Their OmniAb, Inc. (NASDAQ:OABI) Price Target To US$7.88

OmniAb, Inc. (NASDAQ:OABI) Shares Slammed 29% But Getting In Cheap Might Be Difficult Regardless

Apr 20
OmniAb, Inc. (NASDAQ:OABI) Shares Slammed 29% But Getting In Cheap Might Be Difficult Regardless
User avatar

Novel Technologies And Clinical Pipeline Will Unlock Future Possibilities

Strong growth in partners and programs suggests robust future milestone and royalty revenues as technologies attract significant opportunities.

OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Have Been Cutting Their Estimates

Nov 15
OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Have Been Cutting Their Estimates

Is OmniAb (NASDAQ:OABI) In A Good Position To Invest In Growth?

Sep 14
Is OmniAb (NASDAQ:OABI) In A Good Position To Invest In Growth?

Are Investors Undervaluing OmniAb, Inc. (NASDAQ:OABI) By 43%?

Jul 15
Are Investors Undervaluing OmniAb, Inc. (NASDAQ:OABI) By 43%?

The OmniAb, Inc. (NASDAQ:OABI) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 12
The OmniAb, Inc. (NASDAQ:OABI) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Things Look Grim For OmniAb, Inc. (NASDAQ:OABI) After Today's Downgrade

Mar 26
Things Look Grim For OmniAb, Inc. (NASDAQ:OABI) After Today's Downgrade

Revenues Not Telling The Story For OmniAb, Inc. (NASDAQ:OABI)

Feb 28
Revenues Not Telling The Story For OmniAb, Inc. (NASDAQ:OABI)

OmniAb, Inc.'s (NASDAQ:OABI) Intrinsic Value Is Potentially 37% Above Its Share Price

Jan 15
OmniAb, Inc.'s (NASDAQ:OABI) Intrinsic Value Is Potentially 37% Above Its Share Price

Unpleasant Surprises Could Be In Store For OmniAb, Inc.'s (NASDAQ:OABI) Shares

Nov 11
Unpleasant Surprises Could Be In Store For OmniAb, Inc.'s (NASDAQ:OABI) Shares

Earnings Update: OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Are Trimming Their Forecasts

Aug 13
Earnings Update: OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Are Trimming Their Forecasts

OmniAb, Inc. (NASDAQ:OABI) Analysts Just Cut Their EPS Forecasts Substantially

May 14
OmniAb, Inc. (NASDAQ:OABI) Analysts Just Cut Their EPS Forecasts Substantially

CEO Compensation Analysis

How has Matt Foehr's remuneration changed compared to OmniAb's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-US$64m

Jun 30 2025n/an/a

-US$64m

Mar 31 2025n/an/a

-US$61m

Dec 31 2024US$4mUS$594k

-US$62m

Sep 30 2024n/an/a

-US$63m

Jun 30 2024n/an/a

-US$62m

Mar 31 2024n/an/a

-US$63m

Dec 31 2023US$3mUS$564k

-US$51m

Sep 30 2023n/an/a

-US$30m

Jun 30 2023n/an/a

-US$27m

Mar 31 2023n/an/a

-US$22m

Dec 31 2022US$7mUS$542k

-US$22m

Sep 30 2022n/an/a

-US$32m

Jun 30 2022n/an/a

-US$28m

Mar 31 2022n/an/a

-US$25m

Dec 31 2021US$5mUS$519k

-US$27m

Sep 30 2021n/an/a

-US$24m

Dec 31 2020US$3mUS$504k

-US$18m

Compensation vs Market: Matt's total compensation ($USD3.65M) is above average for companies of similar size in the US market ($USD1.45M).

Compensation vs Earnings: Matt's compensation has increased whilst the company is unprofitable.


CEO

Matt Foehr (52 yo)

3.2yrs
Tenure
US$3,647,160
Compensation

Mr. Matthew W. Foehr, also known as Matt, has been the President, Chief Executive Officer and Director of OmniAb, Inc. since November 1, 2022. Mr. Foehr has been the Chief Executive Officer and President a...


Leadership Team

NamePositionTenureCompensationOwnership
Matthew Foehr
President3.2yrsUS$3.65m3.03%
$ 8.1m
Kurt Gustafson
Executive VP of Finance & CFO3.2yrsUS$1.67m0.18%
$ 467.5k
Charles Berkman
Chief Legal Officer & Secretary3.2yrsUS$1.69m0.26%
$ 697.6k
Cia McCaffrey
Vice President of People & Talent3yrsno datano data
Bill Harriman
Senior Vice President of Antibody Discoveryno datano datano data
Christel Iffland
Senior Vice President of Antibody Technologiesno datano datano data
Yasmina Abdiche
Senior Vice President of Exploratory Research1yrno datano data
Todd Pettingill
Vice President of Business Development & Strategyno datano datano data
3.2yrs
Average Tenure
56yo
Average Age

Experienced Management: OABI's management team is considered experienced (3.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Matthew Foehr
President3.2yrsUS$3.65m3.03%
$ 8.1m
John Higgins
Chairman3.2yrsUS$258.04k1.61%
$ 4.3m
Carolyn Bertozzi
Independent Director3.2yrsUS$254.71k0.065%
$ 172.6k
Steven Love
Independent Director2.2yrsUS$248.36k0.050%
$ 132.6k
Philip Gotwals
Independent Directorless than a yearno datano data
Steven Crouse
Independent Directorless than a yearno datano data
Jennifer Cochran
Independent Director3.2yrsUS$254.89k0.11%
$ 285.3k
3.2yrs
Average Tenure
55yo
Average Age

Experienced Board: OABI's board of directors are considered experienced (3.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/06 02:50
End of Day Share Price 2026/01/05 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

OmniAb, Inc. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert WassermanBenchmark Company
Matthew HewittCraig-Hallum Capital Group LLC
Joseph PantginisH.C. Wainwright & Co.